Dividend share reviews
Should I sell my Direct Line Insurance shares?
Direct Line Insurance (LON:DLG) had a difficult time last year. Roland Head reviews the insurer's 2022 results and flags up his concerns.
Dividend share reviews
Direct Line Insurance (LON:DLG) had a difficult time last year. Roland Head reviews the insurer's 2022 results and flags up his concerns.
Portfolio
I review February's results from five shares in my quality dividend model portfolio.
Podcasts
I've recorded a podcast with Maynard Paton discussing Telecom Plus (LON:TEP) shares. After a 25% share price drop, is it time to buy?
Dividend share reviews
FTSE 100 pharma group GSK (LON:GSK) has streamlined its business and its financial health seems to be improving. Should I consider the shares for my dividend portfolio?
Portfolio
I review January's news from three stocks my quality dividend model portfolio, including the latest from troubled insurer Direct Line Insurance (LON:DLG).
Podcasts
I've recorded a podcast discussing antibody specialist Bioventix (LON:BVXP) with Maynard Paton. We explain why we think this is such a special business - and consider what could go wrong.
Dividend share reviews
Aviva (LON:AV) shares now offer a 7% dividend yield and the prospect of steady growth. Is it time to buy this perennial underperformer?
Portfolio
I review results from a small-cap stock in my dividend portfolio and explain what I'm going to do following Direct Line's dividend cancellation.
Portfolio
I review the performance of my quality dividend portfolio in 2022, including dividend income, trading activity and comments on the outlook for 2023.
Dividend share reviews
FTSE 250 real estate group Savills (LON:SVS) looks cheaper than it has done since 2008 according to several key metrics. Should I consider buying this dividend stock for my income portfolio?
Portfolio
I review November's results from my quality dividend model portfolio. Four FTSE 100 stocks are covered in the report, including a high yielder and an energy business.
Dividend share reviews
FTSE 100 dividend stock Hargreaves Lansdown looks cheaper than it has done since 2008 and offers a tempting 5% yield. Should I consider buying this market leader for my income portfolio?
Disclaimer: All content provided on this website is intended for educational and entertainment purposes only. This website does not provide investment advice or recommendations. You should research all investment decisions yourself and not rely upon information provided on this website. If you are unable to do this you should seek professional advice from a registered financial adviser.